725-066 FY27 Recompete RPMS First Data Bank database

Past Recompete Updated

Agency
Solicitation expected
Estimated value
$700,000 to $1,500,000
Set-aside
No set-aside

Forecast facts

Incumbent contract
Anticipated award
NAICS code
Not on record
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Indian Health Service is recompeting a contract for First Data Bank drug information and pricing database services that provide drug-drug interaction checks and pricing data to the Pharmacy Reporting and Management System and the National Drug File, with solicitation release estimated for October 1, 2026, and award estimated for March 1, 2027. The database services support patient safety, regulatory compliance, and financial integrity across the Indian Health Service's pharmacy operations. Contractors must deliver regular updates to DDI checks and pricing data integrated within RPMS and NDF infrastructure.

The estimated award value ranges from $700,000 to $1.5 million. Work is performed in Rockville, Maryland. Darby McNutt, Senior Program Manager – Health IT at Indian Health Service (darby.mcnutt@ihs.gov, 208-238-2400), and Julie Corbin, Contracting Officer (julie.corbin@ihs.gov), are the primary points of contact.

The incumbent contract is a firm fixed-price definitive contract awarded to First Databank Inc. (doing business as Hearst FDB) under contract number 75H70422C00001 on March 17, 2022, valued at $3.92 million, with completion scheduled for March 23, 2027. The existing award covers provision of drug information and pricing database services along with associated decision support tools and renewal services. First Databank specializes in proprietary pharmaceutical and medical knowledge databases and has delivered solutions across multiple federal healthcare agencies including the Department of Veterans Affairs, Defense Health Agency, and Food and Drug Administration.

Forecast text

Database provides regular updates to drug-drug interaction (DDI) checks and pricing data in RPMS and the National Drug File (NDF) are critical for patient safety, regulatory compliance, and financial integrity.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast